History
# Registration date Revision Id
2 2026-09-03, 1405/06/12 394397
1 2023-12-23, 1402/10/02 289274
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • Protocol summary

    This study is a randomized controlled clinical trial that will be conducted on women undergoing mastectomy in selected military centers (Baqiyatullah Aj Hospital and Chamran Hospital). They will be randomly divided into two intervention and control groups using the quadruple block method. Transitional care program in the intervention group will start from the time the patient is admitted and will continue until three months after discharge from the hospital. Also, training will be given to the patient in four sessions (one session before surgery and three sessions once a week until three weeks after discharge for 45 minutes).
    This study is a randomized controlled clinical trial that will be conducted on women undergoing mastectomy surgery in selected military centers (Baqiyatallah Hospital and Chamran Hospital). Sampling will be done using a four-way block method and will be randomly divided into two intervention and control groups. A transitional care program will be implemented for the intervention group. So that the patients will be provided with educational intervention during four sessions (the first session, before discharge in person and three sessions once a week for up to three weeks after discharge by telephone for 45 minutes).
    این مطالعه یک کارآزمایی بالینی تصادفی شاهد دار است که بر روی زنان تحت عمل جراحی ماستکتومی در مراکز منتخب نظامی (بیمارستان بقیه الله عج و بیمارستان چمران) انجام خواهد شد. به روش بلوک بندی چهارتایی به صورت تصادفی در دو گروه مداخله و کنترل تقسیم خواهند شد. برنامه مراقبت انتقالی در گروه مداخله از زمان پذیرش بیمار شروع و تا سه ماه پس از ترخیص از بیمارستان ادامه خواهد یافت. همچنین آموزش ها طی چهار جلسه (یک جلسه قبل از عمل و سه جلسه به صورت هفته ای یکبار تا سه هفته بعد از ترخیص بمدت 45 دقیقه) به بیمار داده خواهد شد.
    این مطالعه یک کارآزمایی بالینی تصادفی شاهد دار است که بر روی زنان تحت عمل جراحی ماستکتومی در مراکز منتخب نظامی (بیمارستان بقیه الله عج و بیمارستان چمران) انجام خواهد شد. نمونه گیری به روش بلوک بندی چهارتایی به صورت تصادفی در دو گروه مداخله و کنترل تقسیم خواهند شد. برنامه مراقبت انتقالی برای گروه مداخله اجرا خواهد شد. به طوری که بیماران مداخله آموزشی طی چهار جلسه ( جلسه اول، قبل از ترخیص به صورت حضوری و سه جلسه به صورت هفته ای یکبار تا سه هفته بعد از ترخیص به صورت تلفنی بمدت 45 دقیقه) به بیمار ارائهخواهد شد.
    Inclusion criteria Patients one to three days after mastectomy Having the age of eighteen to seventy years Breast cancer identified by pathology and treated by surgery Ability to complete the questionnaire independently Access to home phone and mobile phone Not suffering from mental illnesses Exclusion criteria History of chronic diseases Not living in Tehran Women over seventy years old
    Inclusion criteria Hospitalized patients who are on postoperative days 1 to 3 following mastectomy surgery. Having the age of eighteen to seventy years Breast cancer identified by pathology and treated by surgery Ability to complete the questionnaire independently Access to a home phone and mobile phone Not suffering from mental illnesses Exclusion criteria History of chronic diseases Not living in Tehran Women over seventy years old
    شرایط ورود  بیماران یک تا سه روز بعد از ماستکتومی  داشتن سن هیجده الی هفتاد سال  سرطان پستان تشخص داده شده توسط پاتولوژی و درمان شده توسط جراحی  توانایی تکمیل پرسشنامه به طور مستقل  دسترسی به تلفن در منزل و تلفن همراه  عدم ابتلا به بیماری های روانی شرایط عدم ورود سابقه بیماری های مزمن عدم سکونت در تهران زنان بالای هفتاد سال
    شرایط ورود  بیماران بستری در بیمارستان که در روزهای ۱ تا ۳ پس از انجام عمل جراحی ماستکتومی قرار داشته باشند.  داشتن سن هیجده الی هفتاد سال  سرطان پستان تشخص داده شده توسط پاتولوژی و درمان شده توسط جراحی  توانایی تکمیل پرسشنامه به طور مستقل  دسترسی به تلفن در منزل و تلفن همراه  عدم ابتلا به بیماری های روانی شرایط عدم ورود سابقه بیماری های مزمن عدم سکونت در تهران زنان بالای هفتاد سال
    Intervention group: Transitional care program will start from the time of admission of the patient and will continue until three months after discharge from the hospital. Control group: they will go through the usual process of discharge from the hospital (providing an educational brochure, containing educational tips after the operation)
    Women with breast cancer who are candidates for mastectomy and meet the inclusion criteria.
    گروه مداخله: برنامه مراقبت انتقالی از زمان پذیرش بیمار شروع و تا سه ماه پس از ترخیص از بیمارستان ادامه خواهد یافت. گروه کنترل: فرایند معمول ترخیص از بیمارستان (ارائه بروشور آموزشی، حاوی نکات آموزشی بعد از عمل) را طی خواهند نمود
    زنان مبتلا به سرطان پستان کاندید عمل ماستکتومی که دارای معیارهای ورود به مطالعه باشند
  • General information

    2024-01-05, 1402/10/15
    2024-04-20, 1403/02/01
    2024-02-19, 1402/11/30
    2024-07-22, 1403/05/01
    empty
    Minor errors in some parts that were entered during incomplete registration
    empty
    اشکالات نگارشی جزیی در برخی از قسمت ها که در زمان ثبت ناقص وارد شده است
    Patients one to three days after mastectomy
    Breast cancer identified by pathology and treated by surgery
    Ability to complete the questionnaire independently
    Access to home and mobile phones
    Residence in Tehran and its suburbs within one month after discharge for the possibility of home visits
    No mental illness
    Hospitalized patients who are on postoperative days 1 to 3 following mastectomy surgery.
    Breast cancer identified by pathology and treated by surgery
    Ability to complete the questionnaire independently
    Access to home and mobile phones
    Residence in Tehran and its suburbs within one month after discharge for the possibility of home visits
    No mental illness
    بیماران یک تا سه روز بعد از ماستکتومی
    سرطان پستان تشخص داده شده توسط پاتولوژی و درمان شده توسط جراحی
    توانایی تکمیل پرسشنامه به طور مستقل
    دسترسی به تلفن در منزل و تلفن همراه
    سکونت در تهران و حومه طی یکماه پس از ترخیص جهت امکان ویزیت در منزل
    عدم ابتلا به بیماری های روانی
    بیماران بستری در بیمارستان که در روزهای ۱ تا ۳ پس از انجام عمل جراحی ماستکتومی قرار داشته باشند.
    سرطان پستان تشخص داده شده توسط پاتولوژی و درمان شده توسط جراحی
    توانایی تکمیل پرسشنامه به طور مستقل
    دسترسی به تلفن در منزل و تلفن همراه
    سکونت در تهران و حومه طی یکماه پس از ترخیص جهت امکان ویزیت در منزل
    عدم ابتلا به بیماری های روانی
    This study is a randomized controlled clinical trial that will be conducted on women undergoing mastectomy in selected military centers. At first, the samples will be randomly divided into intervention and control groups based on the inclusion criteria and selected in a purposeful way and by the quadruple block method. The method of random assignment with blocks of four will be such that letter A will be assigned to the intervention group and letter B will be assigned to the control group, and in blocks of four with letters A and B, six states AABB, BBAA, ABAB, BABA , ABBA, BAAB will be written on separate sheets and thrown in a container. Randomly, one of these sheets will be taken out of the container and the composition written on it will be noted and that sheet will be thrown into the container again. Since the sample size is 60 patients, this procedure will be repeated fifteen times and each time the composition written on the sheet will be noted down after the composition written on the previous sheet. Then, each letter will be assigned a number from one to sixty in the order of the letters written down one after the other. Each of the letters will be placed in an envelope and numbers from one to sixty will be written on the envelope. Each time a patient is selected, one of these envelopes will be opened in order of the number written on the envelope, and it will be determined in which group the patient will be placed. And after explaining the objectives of the study and obtaining verbal and written informed consent, the people of the control group of the usual process of discharge from the hospital (providing an educational brochure, containing educational tips after the operation, as well as answering questions that some patients randomly asked the researcher or department personnel will be asked) and the researcher will only complete the demographic profile questionnaire with regard to these people by asking them and the information of the patients' files. Also, in the intervention group, the transitional care program will be carried out based on transitional care components and Nanda's nursing diagnoses.
    This study is a randomized controlled clinical trial that will be conducted on women undergoing mastectomy in selected military centers. At first, the samples will be randomly divided into intervention and control groups based on the inclusion criteria and selected in a purposeful way and by the quadruple block method. The method of random assignment with blocks of four will be such that letter A will be assigned to the intervention group and letter B will be assigned to the control group, and in blocks of four with letters A and B, six states AABB, BBAA, ABAB, BABA , ABBA, BAAB will be written on separate sheets and thrown in a container. Randomly, one of these sheets will be taken out of the container and the composition written on it will be noted and that sheet will be thrown into the container again. Since the sample size is 60 patients, this procedure will be repeated fifteen times and each time the composition written on the sheet will be noted down after the composition written on the previous sheet. Then, each letter will be assigned a number from one to sixty in the order of the letters written down one after the other. Each of the letters will be placed in an envelope and numbers from one to sixty will be written on the envelope. Each time a patient is selected, one of these envelopes will be opened in order of the number written on the envelope, and it will be determined in which group the patient will be placed.
    این مطالعه یک کارآزمایی بالینی تصادفی شاهد دار است که بر روی زنان تحت عمل جراحی ماستکتومی در مراکز منتخب نظامی انجام خواهد شد. نمونه ها در ابتدا بر اساس معیارهای ورود و به شکل هدفمند انتخاب و به روش بلوک بندی چهارتایی به صورت تصادفی در دو گروه مداخله و کنترل تقسیم خواهند شد. روش تخصیص تصادفی با بلوک های چهار تایی به این صورت خواهد بود که به گروه مداخله حرف A و به گروه شاهد حرف B اختصاص داده خواهد شد و در بلوک های چهار تایی با حروف A و B, شش حالت AABB، BBAA، ABAB، BABA، ABBA، BAAB در برگه های جداکانه نوشته خواهد شد و در ظرفی انداخته می شود. به صورت تصادفی یکی از این برگه ها رو از ظرف بیرون آورده و ترکیب نوشته شده بر روی آن یادداشت و مجددا آن برگه به داخل ظرف انداخته خواهد شد.چون حجم نمونه شصت بیمار می باشد این عمل پانزده بار تکرار و هر بار ترکیب نوشته شده بر روی برگه به دنبال ترکیب نوشته شده برگه قبلی یادداشت خواهد شد. سپس به هر یک از حروف یک عدد از یک تا شصت به ترتیب حروف یادداشت شده پشت سر هم اختصاص داده خواهد شد. هر یک از حروف داخل یک پاکت گذاشته خواهد شد و روی پاکت اعداد یک تا شصت نوشته خواهد شد. هر بار که بیماری انتخاب شود یکی از این پاکت ها به ترتیب عدد نوشته شده روی پاکت باز خواهد شد و مشخص می شود که بیمار در کدام گروه قرار خواهد گرفت. و پس از توضیح اهداف مطالعه و اخذ رضایت آگاهانه شفاهی و کتبی، افراد گروه کنترل فرایند معمول ترخیص از بیمارستان (ارائه بروشور آموزشی، حاوی نکات آموزشی بعد از عمل و همچنین پاسخ به سؤالاتی که بعضی از بیماران به صورت اتفاقی از پژوهشگر یا پرسنل بخش خواهند پرسید) را طی خواهند نمود و پژوهشگر در رابطه با این افراد فقط پرسشنامه مشخصات دموگرافیک را با پرسش از ایشان و اطلاعات پرونده بیماران تکمیل خواهد نمود. همچنین در گروه مداخله، برنامه مراقبت انتقالی بر اساس اجزاء مراقبت انتقالی و تشخیص های پرستاری ناندا انجام خواهد شد
    این مطالعه یک کارآزمایی بالینی تصادفی شاهد دار است که بر روی زنان تحت عمل جراحی ماستکتومی در مراکز منتخب نظامی انجام خواهد شد. نمونه ها در ابتدا بر اساس معیارهای ورود و به شکل هدفمند انتخاب و به روش بلوک بندی چهارتایی به صورت تصادفی در دو گروه مداخله و کنترل تقسیم خواهند شد. روش تخصیص تصادفی با بلوک های چهار تایی به این صورت خواهد بود که به گروه مداخله حرف A و به گروه شاهد حرف B اختصاص داده خواهد شد و در بلوک های چهار تایی با حروف A و B, شش حالت AABB، BBAA، ABAB، BABA، ABBA، BAAB در برگه های جداکانه نوشته خواهد شد و در ظرفی انداخته می شود. به صورت تصادفی یکی از این برگه ها رو از ظرف بیرون آورده و ترکیب نوشته شده بر روی آن یادداشت و مجددا آن برگه به داخل ظرف انداخته خواهد شد.چون حجم نمونه شصت بیمار می باشد این عمل پانزده بار تکرار و هر بار ترکیب نوشته شده بر روی برگه به دنبال ترکیب نوشته شده برگه قبلی یادداشت خواهد شد. سپس به هر یک از حروف یک عدد از یک تا شصت به ترتیب حروف یادداشت شده پشت سر هم اختصاص داده خواهد شد. هر یک از حروف داخل یک پاکت گذاشته خواهد شد و روی پاکت اعداد یک تا شصت نوشته خواهد شد. هر بار که بیماری انتخاب شود یکی از این پاکت ها به ترتیب عدد نوشته شده روی پاکت باز خواهد شد و مشخص می شود که بیمار در کدام گروه قرار خواهد گرفت.
  • Ethics committees

    #1
    2023-11-29, 1402/09/08
    2023-10-24, 1402/08/02
  • Primary outcomes

    #1
    At the beginning of the study (before the start of the intervention) and three months after the intervention
    before the start of the intervention and three months after the intervention
    ابتدای مطالعه (قبل از شروع مداخله) و سه ماه بعد از مداخله
    قبل از شروع مداخله و سه ماه بعد از مداخله
    Breast Cancer-Specific Quality of Life Questionnaire (QLQ-BR23)
    The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire–Breast Cancer Module (EORTC QLQ-BR30)
    پرسشنامه کیفیت زندگی ویژه سرطان پستان
    پرسشنامه کیفیت زندگی 30 سوالی ویژه سرطان پستان
  • Secondary outcomes

    #1
    At the beginning of the study (before the start of the intervention) and three months after the intervention
    before the start of the intervention and three months after the intervention
    ابتدای مطالعه (قبل از شروع مداخله) و سه ماه پس از مداخله
    قبل از شروع مداخله و سه ماه پس از مداخله
  • Intervention groups

    #1
    The transitional care plan is the coordination and continuity of medical care during the transfer of the patient from one care complex to another complex or home. Care sets, care providers, conditions and care needs in the acute and chronic period of the disease change in this transition period. Supporting the patient during the transition from one phase of illness or treatment to another, such as moving from receiving care in the hospital to care at home, is one of the goals of transitional care. And in the intervention group, it will start from the time the patient is admitted and will continue until three months after discharge from the hospital. Also, trainings will be given to the patient during four sessions (one session before surgery and three sessions once a week until three weeks after discharge for 45 minutes). The researcher will meet the patient eligible to enter the study in the first 24 hours of admission, and after announcing the readiness of the patient and the caregivers to enter the study, they will complete the demographic profile questionnaire and the quality of life and care burden of the caregivers. After the discharge, the researcher will contact the patients or their home caregiver once a week until the end of the intervention and will check the progress of the disease and the achievement of the goals. The time of the first appointment will be determined within seven to ten days after discharge. The duration of phone conversations will change based on the client's needs. The last phone call will be made with the patient in the twelfth week after discharge, during which, in addition to counseling, the necessary coordination for the second and last meeting with the patient will also be done. After the completion of the intervention (twelfth week after discharge), the quality of life and caregiver burden questionnaire will be completed again in both groups by the researcher and during the meeting with the patient. The answers will be analyzed and compared.
    For the intervention group, a structured transitional care program based on these principles will be developed. The program will include four components:1. Preparation for transition:Pre-discharge education on the discharge process, expectations for home care, differences between hospital and home care, and the psychological and physical preparation of patients and caregivers.2. Support and independence:Aims to reduce dependency and increase caregiver and patient self-efficacy through structured education, emotional support, and caregiver participation in providing care.3. How to communicate with the care team4. Integrated and needs-based care:Includes a comprehensive assessment of patient and caregiver needs, personalized care planning, ongoing follow-up, targeted education, and access to support services.The educational content will be delivered by a trained nurse with experience in oncology (researcher) in four sessions (one in person before discharge and three weekly sessions by telephone after discharge, for 45 minutes).In addition to the educational sessions, participants will receive two home visits (at weeks 4 and 8) and weekly telephone follow-ups to assess clinical symptoms, psychosocial status, caregiver needs, and provide tailored counseling. During the home visits, the patients' clinical status (vital signs, blood glucose, weight, mobility, respiratory and mental status) will be monitored and recorded.
    برنامه مراقبت انتقالی هماهنگی و تداوم مراقبت درمانی حین انتقال بیمار از یک مجموعه ی مراقبتی به مجموعه دیگر و یا منزل می باشد. مجموعه های مراقبتی، ارائه دهندگان مراقبتی، شرایط و نیازهای مراقبتی در دوره حاد و مزمن بیماری، در این بازه ی انتقال تغییر می کند. حمایت از بیمار حین انتقال از یک فاز بیماری یا درمان به فاز دیگر مثل جابجایی از دریافت مراقبت در بیمارستان به مراقبت در منزل از اهداف مراقبت انتقالی است. و در گروه مداخله از زمان پذیرش بیمار شروع و تا سه ماه پس از ترخیص از بیمارستان ادامه خواهد یافت. همچنین آموزش ها طی چهار جلسه (یک جلسه قبل از عمل و سه جلسه به صورت هفته ای یکبار تا سه هفته بعد از ترخیص بمدت 45 دقیقه) به بیمار داده خواهد شد. پژوهشگر بیمار واجد شرایط ورود به مطالعه را در ٢٤ ساعت اول پذیرش ملاقات خواهد کرد و پس از اعلام آمادگی بیمار و مراقبین جهت ورود به مطالعه، پرسشنامه مشخصات دموگرافیک و کیفیت زندگی و بار مراقبتی مراقبین را تکمیل خواهند نمود. پس از ترخیص پژوهشگر هفته ای یکبار تا پایان مداخله با بیماران یا مراقب خانگی آنها تماس خواهد گرفت و پیشرفت بیماری و دستیابی به اهداف را بررسی خواهد نمود اولین تماس تلفنی پژوهشگر در ٢٤ ساعت اول پس از ترخیص با بیمار برقرار خواهد شد که علاوه بر مشاوره، زمان اولین ملاقات طی هفت الی ده روز پس از ترخیص با بیمار تعیین خواهد شد. مدت زمان مکالمات تلفنی بر اساس نیازهای مددجو تغییر خواهد یافت. آخرین تماس تلفنی در هفته دوازدهم پس از ترخیص با بیمار برقرار خواهد شد که طی آن علاوه بر مشاوره، هماهنگی لازم جهت دومین و آخرین ملاقات با بیمار نیز به عمل خواهد آمد. پس از اتمام مداخله (هفته دوازده پس از ترخیص) مجددا پرسشنامه کیفیت زندگی و بار مراقبتی مراقبین، در هر دو گروه توسط پژوهشگر و طی ملاقات با بیمار تکمیل خواهد شد. پاسخ ها تجزیه و تحلیل و مقایسه خواهند شد.
    برای گروه مداخله، یک برنامه مراقبت انتقالی ساختارمند بر اساس اصول مراقبت انتقال تدوین خواهد شد. این برنامه شامل چهار جزء :1. آمادگی برای انتقال:آموزش قبل از ترخیص در مورد فرآیند ترخیص، انتظارات مراقبت در منزل و تفاوت‌های بین مراقبت در بیمارستان و منزل، و همچنین آمادگی روانی و جسمی بیماران و مراقبان.2. حمایت و استقلال:با هدف کاهش وابستگی و افزایش خودکارآمدی مراقب و بیمار از طریق آموزش ساختارمند، حمایت عاطفی و مشارکت مراقبان در ارائه مراقبت.3 نحوه ارتباط با تیم مراقبت ۴. مراقبت یکپارچه و مبتنی بر نیاز:شامل ارزیابی جامع نیازهای بیمار و مراقب، برنامه‌ریزی مراقبت شخصی‌سازی‌شده، پیگیری مداوم، آموزش هدفمند و دسترسی به خدمات حمایتی خواهد بود.محتوای آموزشی توسط یک پرستار آموزش‌دیده با تجربه در انکولوژی(پژوهشگر) در چهار جلسه (یکی قبل از ترخیص به صورت حضوری و سه جلسه به صورت هفته ای یکبار پس از ترخیص به صورت تلفنی، به مدت ۴۵ دقیقه ) ارائه خواهد شد. علاوه بر جلسات آموزشی، شرکت‌کنندگان دو بار ویزیت در منزل (در هفته‌های ۴ و ۸) و پیگیری‌های تلفنی هفتگی برای ارزیابی علائم بالینی، وضعیت روانی-اجتماعی، نیازهای مراقب و ارائه مشاوره متناسب دریافت خواهندکرد. در طول ویزیت‌های خانگی، وضعیت بالینی بیماران (علائم حیاتی، قند خون، وزن، تحرک، وضعیت تنفسی و روانی) کنترل و ثبت خواهد شد.
    #2
    Control group: After explaining the objectives of the study and obtaining verbal and written informed consent, the people in the control group were given the usual process of discharge from the hospital (providing an educational brochure, containing post-operative educational tips, as well as answering questions that some patients randomly ask the researcher or staff asked) and the researcher will only complete the demographic profile questionnaire with regard to these people by asking them and the information of the patients' files.
    The control group will receive routine postoperative care as directed
    گروه کنترل: پس از توضیح اهداف مطالعه و اخذ رضایت آگاهانه شفاهی و کتبی، افراد گروه کنترل فرایند معمول ترخیص از بیمارستان (ارائه بروشور آموزشی، حاوی نکات آموزشی بعد از عمل و همچنین پاسخ به سؤالاتی که بعضی از بیماران به صورت اتفاقی از پژوهشگر یا پرسنل بخش خواهند پرسید) را طی خواهند نمود و پژوهشگر در رابطه با این افراد فقط پرسشنامه مشخصات دموگرافیک را با پرسش از ایشان و اطلاعات پرونده بیماران تکمیل خواهد نمود.
    گروه کنترل، مراقبت‌های معمول پس از عمل را طبق دستورالعمل دریافت خواهند کرد
  • Sharing plan

    All people have permission to access data and documents
    Everyone will have access to educational content
    تمامی افراد اجازه دسترسی به داده ها و مستندات را دارند
    همه افراد اجازه دسترسی به محتوای آموزشی خواهند داشت

Protocol summary

Study aim
Investigation and impact of transitional care program from hospital to home on the quality of life of women with breast cancer and the care burden of their caregivers in two intervention and control groups.
Design
A clinical trial with a control group, with parallel groups, not blinded, randomized based on a block of four on 60 patients, due to the lack of drug use, the phase is not valid.
Settings and conduct
This study is a randomized controlled clinical trial that will be conducted on women undergoing mastectomy surgery in selected military centers (Baqiyatallah Hospital and Chamran Hospital). Sampling will be done using a four-way block method and will be randomly divided into two intervention and control groups. A transitional care program will be implemented for the intervention group. So that the patients will be provided with educational intervention during four sessions (the first session, before discharge in person and three sessions once a week for up to three weeks after discharge by telephone for 45 minutes).
Participants/Inclusion and exclusion criteria
Inclusion criteria Hospitalized patients who are on postoperative days 1 to 3 following mastectomy surgery. Having the age of eighteen to seventy years Breast cancer identified by pathology and treated by surgery Ability to complete the questionnaire independently Access to a home phone and mobile phone Not suffering from mental illnesses Exclusion criteria History of chronic diseases Not living in Tehran Women over seventy years old
Intervention groups
Women with breast cancer who are candidates for mastectomy and meet the inclusion criteria.
Main outcome variables
Quality of life, caregiver burden

General information

Reason for update
Minor errors in some parts that were entered during incomplete registration
Acronym
IRCT registration information
IRCT registration number: IRCT20231203060248N1
Registration date: 2023-12-23, 1402/10/02
Registration timing: prospective

Last update: 2026-09-07, 1405/06/16
Update count: 1
Registration date
2023-12-23, 1402/10/02
Registrant information
Name
Marzie sadat Seyed alighadr
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 6552 7557
Email address
marziealighadr25@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-04-20, 1403/02/01
Expected recruitment end date
2024-07-22, 1403/05/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effectiveness of transitional care program from hospital to home on the quality of life of women with breast cancer their family caregiver’s burden
Public title
The effectiveness of transitional care program on the quality of life of women with breast cancer and the care burden of their caregivers
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
Hospitalized patients who are on postoperative days 1 to 3 following mastectomy surgery. Breast cancer identified by pathology and treated by surgery Ability to complete the questionnaire independently Access to home and mobile phones Residence in Tehran and its suburbs within one month after discharge for the possibility of home visits No mental illness
Exclusion criteria:
History of chronic diseases Women over seventy years old Non-residence of the person in Tehran
Age
From 18 years old to 70 years old
Gender
Female
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
This study is a randomized controlled clinical trial that will be conducted on women undergoing mastectomy in selected military centers. At first, the samples will be randomly divided into intervention and control groups based on the inclusion criteria and selected in a purposeful way and by the quadruple block method. The method of random assignment with blocks of four will be such that letter A will be assigned to the intervention group and letter B will be assigned to the control group, and in blocks of four with letters A and B, six states AABB, BBAA, ABAB, BABA , ABBA, BAAB will be written on separate sheets and thrown in a container. Randomly, one of these sheets will be taken out of the container and the composition written on it will be noted and that sheet will be thrown into the container again. Since the sample size is 60 patients, this procedure will be repeated fifteen times and each time the composition written on the sheet will be noted down after the composition written on the previous sheet. Then, each letter will be assigned a number from one to sixty in the order of the letters written down one after the other. Each of the letters will be placed in an envelope and numbers from one to sixty will be written on the envelope. Each time a patient is selected, one of these envelopes will be opened in order of the number written on the envelope, and it will be determined in which group the patient will be placed.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics and Research Committee of Baqiyatullah Azam Educational-Therapeutic Center
Street address
South Bahai Sheikh, Nosrati Alley, Baqiyatullah Aj University of Medical Sciences
City
Tehran
Province
Tehran
Postal code
1435916471
Approval date
2023-10-24, 1402/08/02
Ethics committee reference number
IR.BMSU.BAQ.REC.1402.082

Health conditions studied

1

Description of health condition studied
Breast Cancer
ICD-10 code
C50.9
ICD-10 code description
Malignant neoplasm of breast of unspecified site

Primary outcomes

1

Description
Quality of Life
Timepoint
before the start of the intervention and three months after the intervention
Method of measurement
The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire–Breast Cancer Module (EORTC QLQ-BR30)

Secondary outcomes

1

Description
The care burden of the caregivers
Timepoint
before the start of the intervention and three months after the intervention
Method of measurement
Zarit Care Burden Assessment Questionnaire

Intervention groups

1

Description
For the intervention group, a structured transitional care program based on these principles will be developed. The program will include four components:1. Preparation for transition:Pre-discharge education on the discharge process, expectations for home care, differences between hospital and home care, and the psychological and physical preparation of patients and caregivers.2. Support and independence:Aims to reduce dependency and increase caregiver and patient self-efficacy through structured education, emotional support, and caregiver participation in providing care.3. How to communicate with the care team4. Integrated and needs-based care:Includes a comprehensive assessment of patient and caregiver needs, personalized care planning, ongoing follow-up, targeted education, and access to support services.The educational content will be delivered by a trained nurse with experience in oncology (researcher) in four sessions (one in person before discharge and three weekly sessions by telephone after discharge, for 45 minutes).In addition to the educational sessions, participants will receive two home visits (at weeks 4 and 8) and weekly telephone follow-ups to assess clinical symptoms, psychosocial status, caregiver needs, and provide tailored counseling. During the home visits, the patients' clinical status (vital signs, blood glucose, weight, mobility, respiratory and mental status) will be monitored and recorded.
Category
Other

2

Description
The control group will receive routine postoperative care as directed
Category
Other

Recruitment centers

1

Recruitment center
Name of recruitment center
Baqiyatullah AJ Hospital, Chamran Hospital
Full name of responsible person
Dr. Akram Parandeh
Street address
Sheikh Bahai South, Nosrati Street, Baqiyatullah Aj University of Medical Sciences
City
Tehran
Province
Tehran
Postal code
1435916471
Phone
+98 912 515 7599
Email
akram.parandeh@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Bagheiat-allah University of Medical Sciences
Full name of responsible person
Hassan Abul Qasimi
Street address
South Sheikh Baha'i, Nosrati Street, Baqiyatullah AJ University
City
Tehran
Province
Tehran
Postal code
1435916471
Phone
+98 21 8755 0000
Email
Pchd1391@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Bagheiat-allah University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Bagheiat-allah University of Medical Sciences
Full name of responsible person
Marzieh Sadat Seyyed Aliqader
Position
Nursing master's student
Latest degree
Bachelor
Other areas of specialty/work
Nursery
Street address
Sheikh Bahai South, Nosrati Street, Baqiyatullah Aj University of Medical Sciences
City
Tehran
Province
Tehran
Postal code
1435916471
Phone
+98 21 6448 2797
Email
marziealighadr25@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Bagheiat-allah University of Medical Sciences
Full name of responsible person
Marzieh Sadat Seyyed Aliqader
Position
Nursing master's student
Latest degree
Bachelor
Other areas of specialty/work
Nursery
Street address
Sheikh Bahai South, Nosrati Street, Baqiyatullah Aj University of Medical Sciences
City
Tehran
Province
Tehran
Postal code
1435916471
Phone
+98 21 6448 2797
Email
marziealighadr25@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Bagheiat-allah University of Medical Sciences
Full name of responsible person
Marzieh Sadat Seyyed Aliqader
Position
Nursing master's student
Latest degree
Bachelor
Other areas of specialty/work
Nursery
Street address
Sheikh Bahai South, Nosrati Street, Baqiyatullah Aj University of Medical Sciences
City
Tehran
Province
Tehran
Postal code
1435916471
Phone
+98 21 6448 2797
Email
marziealighadr25@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
All data is shared after de-identifying individuals
When the data will become available and for how long
Six months after the results are published
To whom data/document is available
Everyone will have access to educational content
Under which criteria data/document could be used
Access to the outcomes and results of this study will help others to use transitional care to choose the most effective work on the quality of life of women with breast cancer and the care burden of their caregivers.
From where data/document is obtainable
To receive the data, send an email to the address below marziealighadr25@gmail.com
What processes are involved for a request to access data/document
Correspond by email
Comments
Loading...